BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse
- Status
- COMPLETED
- Phase
- PHASE2
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
- Status
- COMPLETED
- Phase
- PHASE2
PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib Followed by High-Dose Melphalan and Bortezomib as Conditioning Regimen for Tandem Stem Cell Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
- Status
- COMPLETED
- Phase
- PHASE2